Supplementary Figure 2: Clinical and genomic annotations of patients with Mycosis fungoides and Sézary syndrome. | Nature Genetics

Supplementary Figure 2: Clinical and genomic annotations of patients with Mycosis fungoides and Sézary syndrome.

From: Genomic analysis of mycosis fungoides and Sézary syndrome identifies recurrent alterations in TNFR2

Supplementary Figure 2

(a) Somatically acquired mutations in CTCL samples of genes mutated in at least 5% of patients. Identical recurrent mutations marked in blue were validated by Sanger sequencing. Diagnosis of Mycosis fungoides or Sézary syndrome is marked, as is large-cell transformation (LCT). (b) Pathway diagram of canonical NF-κB1 signaling highlighting multiple pathway members altered in the targeted resequencing data set.

Back to article page